Emanuela Rabaiotti

Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer

Giorgia Mangili, Maria Picchio, Sandro Sironi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2006 · 104 citations

Positron Emission Tomography, Health Sciences, Oncologic Imaging +10

Octreotide in the Management of Bowel Obstruction in Terminal Ovarian Cancer

Giorgia Mangili, Massimo Piergiuseppe Franchi, Andrea Mariani et al. · Gynecologic Oncology · 1996 · 98 citations

Surgical Oncology, Gastrointestinal Oncology, Bowel Obstruction +8

Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?

Fedro A. Peccatori, Giorgia Mangili, Alice Bergamini et al. · Human Reproduction · 2017 · 66 citations · Full text

Deleterious Brca Mutations, Oocyte, Fertility Issues +19

Paclitaxel vs Epidoxorubicin plus Paclitaxel as Second-Line Therapy for Platinum-Refractory and -Resistant Ovarian Cancer

Giorgio Bolis, Fabio Parazzini, Giovanna Scarfone et al. · Gynecologic Oncology · 1999 · 63 citations

Oncology, Medicine, Paclitaxel Vs Epidoxorubicin +10

Risk Factors for Varicose Disease Before and During Pregnancy

M Dindelli, Fabio Parazzini, A Basellini et al. · Angiology · 1993 · 62 citations